RedHill Biopharma (Israel) Profile

ILS 169.62  10,096%
1.66Last Month High 179.6 
169.5Trading Day  High 171.3 

RedHill Biopharma Summary

RedHill Biopharma Ltd (RDHL) is traded on Tel Aviv Stock Exchange in Israel. It is located in Tel Aviv, and employs 12 people. The company currently falls under 'Small-Cap' category with current market capitalization of 357.38 M. RedHill Biopharma Ltd has 212.73 M outstanding shares. REDHILL BIOPHARMA has accumulated about 39.44 M in cash with (40.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check RedHill Biopharma Probability Of Bankruptcy

RedHill Biopharma Risk Profiles

Key Fundamentals

RedHill Biopharma Against Markets

Current Ratings  

RedHill Biopharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 97% 
RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinicalstage, proprietary, and orallyadministered small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. more
NameRedHill Biopharma Ltd
Macroaxis Advice
InstrumentIsrael Stock Stocks Directory
Business AddressTel Aviv,
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Contact Number972 3 541 3131
CurrencyILS - Israeli Shekel

Did you try this?

Run My Watchlist Analysis Now

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Hide  View All  NextLaunch My Watchlist Analysis


RedHill Biopharma Corporate Directors
Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director, Ph.D


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas